Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Spotlight
GLP-1s
Interviews
FDA
Strategy
Generics
Biosimilars
Value Added Medicines
Business
Deals
Earnings
Manufacturing
Policy & Regulation
Regulatory Landscape
Drug Pricing
IP & Litigation
Tools & Trackers
What's Next?
Who's Hired?
UK Pricing Tracker
Company Rankings
Podcasts
Conference Coverage
Partner Insights
Generics Bulletin Perspectives
Exploring market-shifting topics for the off-patent sector.
View
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Amgen Introduces Second Stelara Rival In Canada
After Alvotech-Jamp Launch, Wezlana Is Billed As First Biosimilar With All Indications
Mar 05 2024
•
By
David Wallace
Two Stelara biosimilars are now competing in Canada • Source: EyeEm / Alamy Stock Photo
More from Biosimilars
More from Products
